Company intelligence / Profile preview

AMTech

Shenzhen, Guangdong, Chinaamtechsystems.com ↗

Ownership: Private
Development stage: Commercial

Overview

Shenzhen AmTech Bioengineering Ltd., Inc. ("AmTech") is an innovative high-tech enterprise founded in 2017 specializing in the R&D and manufacturing of biological and chemical raw materials, in vitro diagnostic reagents, automatic analyzers, with a strong emphasis on protein engineering. The leadership team has extensive experience from world-renowned pharmaceutical companies with expertise spanning organic chemistry, biochemistry, enzymology, immunology, molecular biology, cell biology, polymer chemistry—particularly focused on new product R&D for the IVD industry.

Modalities: Protein engineering-based productsIn vitro diagnostic reagentsAnalyzers
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on AMTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMTech.

Explore the full profile